- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01629654
Poststroke Fatigue - Developing and Testing a Program to Reduce and Cope With Fatigue
Fatigue is a common complaint after stroke, reported by 39-72% of patients. Poststroke fatigue is related to poor neurological recovery, low level of activities of daily living, decreased quality of life and may possibly affect the ability to return to work. Little is known about strategies addressing post-stroke fatigue and their effectiveness.
Aim: to develop, test and evaluate a health promotion program based on strategies addressing poststroke fatigue.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Fatigue is a common complaint after stroke, reported by 39-72% of patients. It has been shown that poststroke fatigue may be related to poor neurological recovery, low level of activities of daily living and decreased quality of life. However, little is known about strategies to address poststroke fatigue and the effectiveness of such strategies.
Objective The aim of the study is to develop a program based on strategies to address poststroke fatigue and to test and evaluate the program.
Material and Methods Intervention Mapping is the overall approach of the study. It describes a protocol for the development of theory- and evidence-based health promotion programmes.
Step 1) The program is developed based on a needs assessment. Existing knowledge about physical, psychosocial and environmental factors associated with poststroke fatigue is mapped in a literature review.
Step 2) The program will be tested in a pilot study (controlled trial). In addition to conventional treatment, the patients in the intervention group will participate in the program for a period of 12 weeks. The control group will receive conventional treatment only.
Step 3) Evaluation of the program: Primary outcome measure will be fatigue, measured on the Multidimensional Fatigue Inventory-20. Secondary outcome measures will be identified during the development of the program. Patients will be tested at baseline, after 3 months and after 6 months. The effect size in the pilot study will be assessed and will be used in order to estimate the required sample size for a large-scale randomized controlled trial on formally testing the efficacy of the program.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Central Denmark Region
-
Aarhus, Central Denmark Region, Danmark, 8000
- Department of Neurology, Aarhus University Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients with first ever stroke
- > 18 year
- Living in the area of Aarhus(intervention group) and patients living in the area of Holstebro (control group).
- Multidimensional Fatigue Inventory-20/Generel Fatigue > 12.
- The patient must be able to give informed consent
- Walking without person support.
- Walking aids is accepted.
Exclusion Criteria:
- Neurological problems related to acute stroke(severe aphasia, decreased level of conscience or decreased attention)
- Other neurologic or psychiatric deseases (including dementia, non treated depression, misuse of alcohol eller medicin)
- Severe co-morbidity (including cancer, blindness or deathness)
- Not-danish speaking.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Lifestyle counseling
Testing of the teory- and evidence based health promotion program.
Patients will participate in a 13 weeks program.
|
A 13 weeks organized program:
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Multidimensional Fatigue Inventory 20
Tidsram: Change from baseline in MFI-20 at 3 and 6 months
|
The multidimensional Fatigue Inventory 20 is a multidimensional fatigue score covering five dimensions of fatigue: General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Motivation and Activity.
Pathologic Fatigue is defined as a score ≥ 12 on the General Fatigue dimension.
|
Change from baseline in MFI-20 at 3 and 6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
The general self-efficacy scale
Tidsram: Change from baseline in the generel self-efficacy scale at 3 and 6 months
|
The general self-efficacy scale is a scale measuring how individuals cope with distressing situations
|
Change from baseline in the generel self-efficacy scale at 3 and 6 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Marit Kirkevold, Professor, University of Aarhus, Health, Nursing Science
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- TEA2011
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Health promotion program
-
Dartmouth-Hitchcock Medical CenterRobert Wood Johnson Foundation; Endowment for HealthAvslutadMental sjukdomFörenta staterna
-
Instituto Politécnico de LeiriaUniversidade Católica PortuguesaAvslutad
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of California, Los... och andra samarbetspartnersAvslutadHIV-infektioner | KönssjukdomFörenta staterna
-
Steen G HasselbalchNordea-Fonden, DenmarkOkändLivskvalité | Stresspsykologisk | StressfysiologiskDanmark
-
Human Development Research Foundation, PakistanNational Institute of Mental Health (NIMH); University of Washington; World... och andra samarbetspartnersAvslutadBeteendesymtom | Emotionell störning | ADHD | Uppförandestörning | Känslomässig stress | Depression, ångest | Känslomässiga problem | Beteendeproblem | Känslomässigt traumaPakistan
-
University of CalgaryUniversity of AlbertaAktiv, inte rekryterandeHypertoni | Diabetes mellitus, typ 2 | Kroniska njursjukdomar | Kronisk obstruktiv lungsjukdom | Astma | Ischemisk hjärtsjukdom | HjärtsviktKanada
-
University of CalgaryAktiv, inte rekryterandeHypertoni | Diabetes mellitus, typ 2 | Kroniska njursjukdomar | Kronisk obstruktiv lungsjukdom | Astma | Ischemisk hjärtsjukdom | HjärtsviktKanada
-
University of CalgaryUniversity of AlbertaAktiv, inte rekryterandeHypertoni | Diabetes mellitus, typ 2 | Kroniska njursjukdomar | Kronisk obstruktiv lungsjukdom | Astma | Ischemisk hjärtsjukdom | HjärtsviktKanada
-
Adebola AdegboyegaNational Cancer Institute (NCI)Rekrytering
-
BaycrestAvslutadDemens | Lätt kognitiv funktionsnedsättning | Demensförebyggande | Subjektiv kognitiv funktionsnedsättning | Pre-demensKanada